Pharmaceutical Development expert with significant experience in phase 1-4 global development in multiple therapeutic areas, including cardiovascular, endocrine (diabetes), rheumatology, gastroenterology, CNS and oncology. Successfully managed large and small programs, both in-house as well as co-development with small and large Pharma companies.Built global development organization based in the US for a foreign-based pharmaceutical company.Directed and/or supervised NDA/MAA submissions resulting in approval and launch of 7 products in multiple regions.Experienced in in- and out-licensing activities and in working with outsourcing (CROs) and academic (AROs) partners.Board certified in Internal Medicine and Rheumatology, Fellow of the American College of Physicians and the American College of Rheumatology, member of multiple professional societies in the US and abroad, extensive publications.Specialties: Global Development, Planning and implementation of global mega-trials, Phase 1-4, Co-developed products, CRO and ARO management, Transcultural collaborations, cardiovascular, endocrine (diabetes), rheumatology, gastroenterology, CNS, oncology, Cross therapeutic area expertise, in-licensing opportunity assessment, medical affairs, lifecycle management planning